Terapias Avanzadas para Tumores Sólidos Pediátricos
University of Nebraska Medical Center
Omaha, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Nebraska Medical Center (1)
2012
-
Phase II study of first-line sagopilone plus prednisone in patients with castration-resistant prostate cancer: A phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium
British Journal of Cancer, Vol. 107, Núm. 5, pp. 808-813